References
- Neill M A, Opal S M, Heelan J, Giusti R, Cassidy J E, White R, Mayer K H. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis; experience during an outbreak in health care workers. Ann Intern Med 1991; 114: 195–199
- Shungu D L, Weinberg E, Gadesbusch H H. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother 1983; 23: 86–90
- Holmes B, Brodgen R N, Richards D M. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1985; 30: 482–513
- Edlund C, Bergan T, Josefsson K, Solberg R, Nord C E. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple dose pharmacokinetics. Scand J Infect Dis 1987; 19: 113–121
- Rogerie F, Ott D, Vandepitte J, Verbist L, Lemmens P, Habiyaremye I. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type I in adults. Antimicrob Agents Chemother 1986; 29: 883–886
- DuPont H L, Corrado M L, Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med 1987; 82(Suppl. 6B)79–83
- Lolekha S, Patanachareon S, Thanangkui B, Vibulbandhitkit S. Norfloxacin versus cotrimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study. Scand J Infect Dis 1988; 20(Suppl 56)35–45
- Wiström J, Norrby R, Burman L G, Lundholm R, Jellheden B, Englund G. Norfloxacin versus placebo for prophylaxis against traveller's diarrhoea. J Antimicrob Chemother 1987; 20: 563–574
- Pichler H ET, Dirdl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhoea. Am J Med 1987; 82: 329–332
- DuPont H L, Ericsson C D, Mathewson J J, DuPont M W. Five versus three days of ofloxacin therapy for traveller's diarrhoea: a placebo-controlled study. Antimicrob Agents Chemother 1992; 36: 87–91
- Petrucelli B P, Murphy G S, Sanchez J L, Walz S, DeFraites R, Gelnett J, Haberberger R L, Echeverria P, Taylor D N. Treatment of traveller's diarrhoea with ciprofloxacin and loperamide. J Infect Dis 1992; 165: 557–560
- Mattila L, Peltola H, Siitonen A, Kyrönseppä H, Simula I, Kataja M. Short-term treatment of traveler's diarrhoea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis 1993; 17: 779–782
- Asperilla M O, Smego R A, Jr, Scott L K. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis 1990; 12(5)873–889
- Goodman L J, Trenholme G M, Kaplan R L, Segreti J, Hines D, Petrak R, Nelson J A, Mayer K W, Landau G W, Levin S. Empiric antimicrobial therapy of domestically acquired acute diarrhoea in urban adults. Arch Intern Med 1990; 150: 541–546
- Aserkov B, Bennett J V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med 1969; 281: 646–640
- Wiström J, Jetborn M, Ekwall E, Norlin K, Söderquist B, Strömberg A, Lundhclm R, Hogevik H, Lagergren L. Englund G, Norrby R and the Swedish Study Group. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Ann Intern Med 1992; 117: 202–208
- Carlstedt G, Dahl P, Niklasson P M, Gullberg K, Banck G, Kahlmeter G. Norfloxacin treatment of salmonellosis does not shorten the carrier state. Scand J Infect Dis 1990; 22: 553–556